CLINICAL_TRIALS
trial_result
· 2023-01-04
Clinical Trial Update: A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure [Phase 2]
Summary
Phase 2 trial assessing the effectiveness of Sitaxsentan Sodium in diastolic heart failure has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diastolic Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2023-01-04